FDA 483 OBSERVATION · #79 OF 1,945 MOST-CITED

Sanitation of non-food-contact surfaces - Manner and frequency

FDA cited this observation 342 times across 315 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods342
BY FISCAL YEAR
FY20272
FY202630
FY202540
FY202441
FY202334
FY202236
FY202119
FY202025
FY201946
FY201857
FY201712

What this observation means, and how to comply

SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.

21 CFR 117.35(e)

Non-food-contact surfaces of equipment — frames, legs, exteriors, and adjacent structures — were not cleaned in a manner and as frequently as necessary to protect against contamination of food and food-contact surfaces. The finding is about the surrounding, not directly contacting, surfaces.

Why FDA writes it — Non-food-contact surfaces accumulate soil, condensate, and microbial niches that transfer to food-contact surfaces and product through splash, aerosol, and handling; neglecting them lets an environmental pathogen like Listeria establish and spread from the equipment periphery.

HOW TO COMPLY
  • Include equipment framework, exteriors, and adjacent non-contact surfaces in the master sanitation schedule.
  • Set cleaning manner and frequency for these surfaces based on their proximity and transfer risk to product zones.
  • Verify effectiveness through environmental monitoring focused on non-contact niches, and act on positives.
  • Trend recurring soiled non-contact areas and eliminate the harborage or condensate source behind them.
WHY FIRMS GET CITED
  • Sanitation focus stops at food-contact surfaces, leaving equipment exteriors and framework under-cleaned.
  • Non-contact niches are hard to reach and get abbreviated cleaning, so environmental risk builds up unseen.
PROFESSIONAL · REMEDIATION PLAYBOOK · SPEQ SYNTHESIS

How to close this finding — and stop it recurring

CHECKING ACCESS

Checking your access…

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.2× the rate of the average FDA-cited firm (9.5% vs 7.8%), across 315 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

You did not clean your non-food contact surface in a manner and as frequently as necessary to protect against contamination.

Heritage Short Bread, Inc. · Hilton Head Island, South Carolina · Foods · 2026-10-22

You did not clean your non-food contact surface in a manner and as frequently as necessary to protect against allergen cross-contact and contamination.

Home Foods, Inc. · Omaha, Nebraska · Foods · 2026-10-07

You did not clean your non-food contact surface in a manner and as frequently as necessary to protect against contamination.

Fairfield Specialty Eggs Inc · Deer Grove, Illinois · Foods · 2026-09-09

You did not clean your non-food contact surface in a manner and as frequently as necessary to protect against allergen cross-contact.

Sunshine Peanut Company · Jacksonville, Florida · Foods · 2026-08-21

You did not clean your non-food contact surface in a manner and as frequently as necessary to protect against contamination.

Dady Premier Catering LLC · San Antonio, Texas · Foods · 2026-08-13

You did not clean your non-food contact surface in a manner and as frequently as necessary to protect against contamination.

North Star Distributors, Inc. · Brockton, Massachusetts · Foods · 2026-06-25

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Contamination control →Food industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →